Biosimilar Insulin: Unraveling The Benefits Of Cost & Accessibility

Speciality: Endocrinology


Speaker:

Dr. Manoj Chawla | MBBS, Diabetologist

Dr. Suresh Damodharan | MRCP (UK), MBBS, Endocrinologist, Internal Medicine, Sexologist

Description:

A warm welcome to all the medical practitioners in this interesting session on untangling the benefits of  biosimilar insulin in terms of cost and access.

Insulin is a hormone secreted from pancreas that helps blood sugar to enter the body's cells so it can be used for energy. Insulin also signals the liver to store blood sugar for later use. It is one of the important components that helps in controlling diabetes in patients.

The speakers Dr. Manoj Chawla and Dr. Suresh Damodharan have provided an elaborative knowledge on the needs of biosimilar insulin with respect to cost and access in the management of diabetes in patients.

Biosimilar insulins are manufactured in living organisms (e.g., yeast and bacteria) to produce large quantities of the product, which limits the ability to manufacture exact replicas of original biological medications. The manufacture and use of biosimilar insulin will be much cost effective and can be used in lower or middle income countries. 

Therefore, listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
 


See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Early Tislelizumab May Boost PFS in Esophageal Cancer

2.

BMTs that are "half-matched" are effective in treating severe sickle cell disease.

3.

Despite reports of hundreds of cancer cases, carcinogens have been discovered at nuclear missile sites in Montana.

4.

Obesity-associated cancers may be on the rise in Puerto Rico

5.

Chris Hoy reveals that he has terminal cancer?here's how to spot early signs of prostate cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot